4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-000609
CHIEF FINANCIAL OFFICER sold 12,000 shares at $20.00 ($240,000)
- CHIEF FINANCIAL OFFICER acquired 12,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-01-03 | Option exercise 10b5-1 | +12,000 | $8.83 | $105,960 | 27,632 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-01-03 | Sale 10b5-1 | −12,000 | $20.00 | $240,000 | 15,632 | D |
| Derivatives | |||||||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-01-03 | Option exercise · Share Option 10b5-1 | −12,000 | 0 | D | ||
| Open-market sales · 12,000 sh · avg $20.00 · $240,000 | |||||||
Loading xslF345X05/form4-01042024_040113.xml…